With all of the claims made by parents of patients who suffer from various seizure disorders or by the patients themselves regarding marijuana's ability to reduce or eliminate seizures, it almost seems common knowledge that the plant has anti-seizure properties. That being said, this anecdotal evidence is only as good as the clinical research that is able to support it, and unfortunately United States drug laws severely limit this research.
Now, a recent analysis performed by doctors Daniel Friedman and Orrin Devinsky seems to back these claims. The doctors reviewed several clinical trials involving cannabinoids and realized there was potential for treating epilepsy. Friedman explained, "When you look at the combined weight of animal data, it appears that cannabidiol appears to have the most consistent anti-seizure effect." In addition, Epidiolex, which is 99% CBD, reduced seizures by 50% or in 2/5 of all patients in one study, or eliminated seizures by 50% in 137 of 213 patients in another study.
Even though the current clinical research on medical marijuana is lacking, many medical communities and research foundations are coming out in support of removing barriers and allowing access to the plant for further studying its effects on epilepsy. Even the Epilepsy Foundations expresses an interest in exploring CBD's ability to treat seizure disorders.
Many states on a local level have enacted CBD-only laws, but these laws seem insufficient, as research suggests cannabinoids work better supplementing each other in what is called the entourage effect. On a national level, the United States still has a long way to go to improve access to medical marijuana and remove barriers to researching it's therapeutic properties.
Visit Marijuana Investor News to read more about these recent studies that back the claims that marijuana is an effective way for reducing or eliminating seizures.